SUBSCRIBE
SUBSCRIBE
News   Business

Lonza Group Ltd. and Osiris Therapeutics, Inc. Enter Strategic Product Supply Agreement

July 2, 2008 | 
1 min read
Lonza (SWX: LONN), today announces a clinical and commercial manufacturing agreement with Osiris Therapeutics, Inc. (NASDAQ:OSIR) for the production of Prochymal®, their leading adult stem cell therapy
Alliances Europe
Lonza
MORE ON THIS TOPIC
Roche's tower in Shanghai, China
Deals
Roche Keeps the Deals Coming With up to $1.7B SangeneBio RNAi Pact
February 3, 2026
 · 
1 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
GSK Puts up to 350 US, UK Jobs on the Chopping Block
February 3, 2026
 · 
49 min read
 · 
BioSpace Editorial Staff
Dashed line from pills isolated on white
Rare diseases
GSK Hands RNA Editor Back to Wave After Underwhelming Early AATD Data
February 2, 2026
 · 
2 min read
 · 
Tristan Manalac
Welcome to Pennsylvania sign at the Pennsylvania/New York state line along Interstate 90.
Manufacturing
Eli Lilly Commits $3.5B To Build Injectable Obesity Drug Plant in PA
February 2, 2026
 · 
2 min read
 · 
Nick Paul Taylor